MedTrace Logo

Muscle Energy Technique With and Without Patellar Inferior Glide in Patients With Patellofemoral Pain Syndrome

NCT07064044 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-07-14

No results posted yet for this study

Summary

Patellofemoral pain syndrome (PFPS) is one of the most commonly diagnosed conditions among adolescents and adults with knee complaints, accounting for approximately 25% of knee disorders diagnosed in sports medical clinics. While the etiology of PFPS is suggested to be multifactorial, several contributing factors such as lower knee extensors strength, quadriceps imbalance, weak hip abductors and overuse have been identified.

Conditions

  • Patellofemoral Pain Syndrome

Interventions

OTHER

Conventional Traetment

TENS applied for 10 minutes, Therapeutic ultrasound,Hip abductors and lateral rotators strengthening, Hamstring muscle passive stretching, Isometrics for quadriceps, given thrice a week for 4 weeks .

OTHER

Muscle Energy Technique and Patellar Inferior Glide

Muscle Energy Technique for Hamstrings and Quadriceps While the patient contract muscle (Hamstring / Quadriceps) the therapist applies a gentle controlled force. After the contraction patient release and the therapist reposition the leg into a new barrier. Intensity of contraction will be 20-25-% of maximum strength. Each contraction will be held for 5-7 seconds, followed by additional passive stretching maintained for 30 and the relaxation patellar inferior glide applied at patella: the examiner applied a gentle downward force on the patella with their right hand, while the left hand controlled the direction of the patella's movement. This will be applied for 3-4 minutes as tolerated by the patient.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Samrood Akram, PhD* · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-31
Primary Completion
2025-10-31
Completion
2025-10-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07064044 on ClinicalTrials.gov